Whole-genome analysis informs breast cancer response to aromatase inhibitionMatthew J. Ellis, Mark A. Watson, Li Ding et al.|Nature|2012Cited by 1k
Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074Joon H. Uhm, Kurt A. Jaeckle, Karla V. Ballman et al.|International Journal of Radiation Oncology*Biology*Physics|2010Cited by 186
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial CarcinomaAndrea B. Apolo, Jonathan E. Rosenberg, Gurkamal Chatta et al.|New England Journal of Medicine|2024Cited by 145
Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft modelGaspar J. Kitange, Jann N. Sarkaria, Brett L. Carlson et al.|Journal of Neuro-Oncology|2008Cited by 97
ETCTN 10563: A phase I study of peposertib and liposomal doxorubicin for advanced or metastatic leiomyosarcoma and other sarcomas.Candace L. Haddox, Suzanne George, Karla V. Ballman et al.|Journal of Clinical Oncology|2025Cited by 1